( en | de | ru )

 

Disambiguation of "Wennerberg, Krister"

Author of the publication

copydeleteadd this publication to your clipboard
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer.

, , , , , , , , , , , , , , , , , and . Briefings Bioinform., (2021)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Krister Helbing

Dag Wennerberg

Göran Wennerberg

Krister Bergmann

Krister Jehmlich

 

Other publications of authors with the same name

Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression., , , and . Bioinform., 33 (14): i359-i368 (2017)Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis., , , , , , and . J. Chem. Inf. Model., 54 (3): 735-743 (2014)Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles., , , , , , , , and . Database J. Biol. Databases Curation, (2018)Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing., , , , , and . Briefings Bioinform., 21 (1): 211-220 (2020)Exploration of databases and methods supporting drug repurposing: a comprehensive survey., , , , , and . Briefings Bioinform., 22 (2): 1656-1678 (2021)Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments., , , , , , , , , and 9 other author(s). Briefings Bioinform., (2022)Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways., , , , , , and . PLoS Comput. Biol., (2013)Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data., , , , , , , , and . Bioinform., 31 (23): 3815-3821 (2015)Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach., , , and . Bioinform., 34 (8): 1353-1362 (2018)Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis., , , , , and . Bioinform., 30 (17): 497-504 (2014)